Our lab develops nanoparticles as tools to study biological barriers and to overcome these barriers at mucosal surfaces to improve drug delivery and immunotherapy. One of the most notable developments is the COVID-19 vaccines by Pfizer, BioNTech,
Bu içeriğe erişmek için giriş yapın veya ücretsiz denemenizi başlatın